Key Dates
June 17, 2025
Related Announcements
- June 5, 2025 - Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional). See NOFO PAR-25-438.
Issued by
National Center for Advancing Translational Sciences (NCATS)
Purpose
The purpose of this notice is to inform potential applicants of a change in the key dates for notice of funding opportunity (NOFO) PAR-25-438 - Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional). Specifically, the July 07, 2025 application due date has been removed.
The following section of PAR-25-438 has therefore been modified:
Currently Reads:
Part 1. Overview Information
Key Dates
| Application Due Dates | Review and Award Cycles | ||||
|---|---|---|---|---|---|
| New | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
| July 07, 2025 | July 07, 2025 | Not Applicable | July 2025 | August 2025 | September 2025 |
| October 16, 2025 | October 16, 2025 | Not Applicable | March 2026 | May 2026 | July 2026 |
Modified to Read (key change is the removal of the July 7, 2025 application due date):
Part 1. Overview Information
Key Dates
| Application Due Dates | Review and Award Cycles | ||||
|---|---|---|---|---|---|
| New | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
| October 16, 2025 | October 16, 2025 | Not Applicable | March 2026 | May 2026 | July 2026 |
All other aspects of the NOFO remain unchanged.
Inquiries
Please direct all inquiries to:
Tiina K. Urv, Ph.D.
National Center for Advancing Translational Sciences (NCATS)
Telephone: 301-827-2746
Email: [email protected]
and Human Services (HHS)
